A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)
Clinical trial NCT02656173 · COMPLETED
Trial details
- NCT number
- NCT02656173
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-25
- Primary completion
- 2017-07-21
- Enrollment
- 568
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.